A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression

A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression

Background: The majority of antidepressants have been reported to cause metabolic syndrome (MetS). Paucity of information available for the effect of Vortioxetine on MetS. The study aims to assess the systematic review of Vortioxetine on depressive patients' blood pressure (BP), central obesity...

Full description

Bibliographic Details
Main Authors: Karthik Sankar, Sushma Viswanathan, Uma maheswari mugundan, Roshini Kizhakkedeth Nazar, Saranya Ramasamy, Rajanandh Muhasaparur Ganesan
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Health Sciences Review
Subjects:
Metabolic syndrome
Metabolic risk parameters
Serotonin modulator
Major depressive disorder
Antidepressant
Online Access:http://www.sciencedirect.com/science/article/pii/S2772632023000557

Internet

http://www.sciencedirect.com/science/article/pii/S2772632023000557

Similar Items